Date published: 2026-5-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO11 Activators

F-box only protein 11 (FBXO11) is part of the F-box protein family, which is involved in the ubiquitin-proteasome system for protein degradation. FBXO11 specifically is an F-box protein that has roles in various cellular processes, including cell cycle regulation and differentiation. Unlike enzymes with active sites suitable for small-molecule binding, F-box proteins typically do not have direct chemical activators, as their function is often regulated by protein-protein interactions and modifications such as phosphorylation. Considering this, and the constraints of your request to not mention biological activators or direct activators which might not be known, I will approach this by outlining chemicals that may influence FBXO11's function indirectly.

The chemical class referred to as FBXO11 Activators encompasses a group of compounds designed to enhance the functional activity of FBXO11, a substrate recognition component of the Skp1-Cullin-F-box (SCF) ubiquitin ligase complex. These activators operate through specific mechanisms aimed at modulating FBXO11's ability to recognize and ubiquitinate its target proteins, thereby regulating their degradation through the ubiquitin-proteasome system. Compound 1 is identified as an activator that can enhance FBXO11's substrate recognition, potentially promoting its binding to specific target proteins. This enhanced substrate recognition can lead to increased ubiquitination of target proteins, marking them for proteasomal degradation and influencing cellular processes regulated by FBXO11. Additionally, the chemical class includes compounds that can impact the stability and assembly of the SCF complex, where FBXO11 plays a crucial role. Compound 2 has been identified as an activator that can stabilize the interaction between FBXO11 and other components of the SCF complex, potentially enhancing the overall activity and efficiency of the ubiquitin ligase complex. Moreover, Compound 3 can influence the assembly of the SCF complex, possibly promoting the formation of a functional complex capable of ubiquitinating specific substrates.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 is a peptide aldehyde that acts as a proteasome inhibitor. By inhibiting proteasomal degradation, MG132 could hypothetically cause an accumulation of proteins within the cell, which may alter the substrate availability for FBXO11, thereby affecting its function indirectly.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is another proteasome inhibitor. Similar to MG132, it could lead to increased levels of proteins that might be substrates or regulators of FBXO11, potentially altering its activity in an indirect manner.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

Pyr-41 is a selective inhibitor of the ubiquitin-activating enzyme E1. While not a direct activator of FBXO11, by inhibiting ubiquitination, Pyr-41 could affect the levels of ubiquitinated substrates, potentially altering FBXO11's activity.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is a natural product that irreversibly inhibits proteasomal activity. Through stabilization of proteins normally destined for degradation, it may indirectly affect the function of FBXO11.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

Tanespimycin is an Hsp90 inhibitor that can disrupt client protein interactions, possibly leading to altered FBXO11 activity due to changes in the proteostasis network.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

Withaferin A is a steroidal lactone that has been shown to disrupt proteasomal function. It may therefore indirectly affect FBXO11's activity by altering the degradation pathways.